Shuttle Pharmactcls Hldgs Inc.
13F holders, Q4 2025 (December 31)9holders +3
4new positions
1sold out
$1.80avg. 13F price*
At the end of Q4 2025, 9 institutions reported holding Shuttle Pharmactcls Hldgs Inc. in their 13F filings, up 3 from Q3 2025. 4 opened new positions and 1 sold out. The largest holders were Ikarian Capital, LLC ($124K), Boothbay Fund Management, LLC ($37K) and Geode Capital Management, LLC ($26K).
- Company
- Shuttle Pharmactcls Hldgs Inc.
- CUSIP
- 825693401
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $187K |
| Exits | 1 | $152K |
All 13F filers, Q3 2025 → Q4 2025: 115,741 shares bought and 43,033 shares sold, net +72,708 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Ikarian Capital, LLC | 0.02% | New | 68,993 | $124K |
| Boothbay Fund Management, LLC | 0.00% | New | 20,360 | $37K |
| Geode Capital Management, LLC | 0.00% | New | 14,444 | $26K |
| UBS Group AG | 0.00% | Add +149237.5% | 11,947 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -20.0% | 812 | $1K |
| Morgan Stanley | 0.00% | No change | 27 | $49 |
| Bank of America Corp. | 0.00% | Add +50.0% | 12 | $22 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 2 | $4 |
| Citigroup Inc. | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is SHUTTLE PHARMACTCLS HLDGS IN's weight in each manager's 13F, not the share of Shuttle Pharmactcls Hldgs Inc. the manager owns.